Advanced search
Publication Cover
Future Microbiology Volume 4, 2009 - Issue 9
Submit an article Journal homepage
293
Views
0
CrossRef citations to date
0
Altmetric
Research Report

Attributable Mortality of Stenotrophomonas Maltophilia Infections: A Systematic Review of the Literature

Matthew E Falagasa Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece and Department of Medicine, Henry Dunant Hospital, Athens, Greece and Department of Medicine, Tufts University School of Medicine, Boston, MA, USA. Tel.: +30 694 611 0000 Fax: +30 210 683 [email protected]
,
Antonia C Kastorisb Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece
,
Evridiki K Vouloumanoub Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece
,
Petros I Rafailidisc Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece and Department of Medicine, Henry Dunant Hospital, Athens, Greece
,
Anastasios M Kapaskelisc Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece and Department of Medicine, Henry Dunant Hospital, Athens, Greece
&
George Dimopoulosd Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece and Department of Critical Care, University Hospital “Attikon”, Medical School, University of Athens
Pages 1103-1109 | Published online: 06 Nov 2009

Bibliography

  • Pompilio A , PiccolominiR, PiccianiC, D‘AntonioD, SaviniV, Di Bonaventura G: Factors associated with adherence to and biofilm formation on polystyrene by Stenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. FEMS Microbiol. Lett.287 , 41–47 (2008).
  • Ryan RP , MonchyS, CardinaleM et al.: The versatility and adaptation of bacteria from the genus Stenotrophomonas.Nat. Rev. Microbiol.7 , 514–525 (2009).
  • Passerini de Rossi B , CalendaM, VayC, FrancoM: Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections.Rev. Argent Microbiol.39 , 204–212 (2007).
  • Calza L , ManfrediR, ChiodoF: Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.Infection31 , 155–161 (2003).
  • Looney WJ , NaritaM, MuhlemannK: Stenotrophomonas maltophilia: an emerging opportunist human pathogen.Lancet Infect. Dis.9 , 312–323 (2009).
  • Safdar A , RolstonKV: Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.Clin. Infect. Dis.45 , 1602–1609 (2007).
  • Sakhnini E , WeissmannA, OrenI: Fulminant Stenotrophomonas maltophilia soft tissue infection in immunocompromised patients: an outbreak transmitted via tap water.Am. J. Med. Sci.323 , 269–272 (2002).
  • Lai CH , ChiCY, ChenHP et al.: Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.J. Microbiol. Immunol. Infect.37 , 350–358 (2004).
  • Spicuzza L , SciutoC, VitalitiG, Di Dio G, Leonardi S, La Rosa M: Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur. J. Clin. Microbiol. Infect. Dis.28 , 191–195 (2009).
  • Denton M , KerrKG: Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.Clin. Microbiol. Rev.11 , 57–80 (1998).
  • Figueiredo PM , FurumuraMT, SantosAM et al.: Cytotoxic activity of clinical Stenotrophomonas maltophilia.Lett. Appl. Microbiol.43 , 443–449 (2006).
  • Hagemann M , HasseD, BergG: Detection of a phage genome carrying a zonula occludens like toxin gene (zot) in clinical isolates of Stenotrophomonas maltophilia.Arch. Microbiol.185 , 449–458 (2006).
  • McKay GA , WoodsDE, MacDonaldKL, PooleK: Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance.Infect. Immun.71 , 3068–3075 (2003).
  • Wu PS , LuCY, ChangLY et al.: Stenotrophomonas maltophilia bacteremia in pediatric patients: a 10-year analysis.J. Microbiol. Immunol. Infect.39 , 144–149 (2006).
  • Tsai WP , ChenCL, KoWC, PanSC: Stenotrophomonas maltophilia bacteremia in burn patients.Burns32 , 155–158 (2006).
  • Boktour M , HannaH, AnsariS et al.: Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients.Cancer106 , 1967–1973 (2006).
  • Caylan R , AydinK, KoksalI: Meningitis caused by Stenotrophomonas maltophilia: case report and review of the literature.Ann. Saudi Med.22 , 216–218 (2002).
  • Gasparetto EL , BertholdoDB, DavausT, MarchioriE, EscuissatoDL: Stenotrophomonas maltophilia pneumonia after bone marrow transplantation: case report with emphasis on the high-resolution CT findings.Br. J. Radiol.80 , e19–e20 (2007).
  • Marshall WF , KeatingMR, AnhaltJP, SteckelbergJM: Xanthomonas maltophilia: an emerging nosocomial pathogen.Mayo Clin. Proc.64 , 1097–1104 (1989).
  • Teo WY , ChanMY, LamCM, ChongCY: Skin manifestation of Stenotrophomonas maltophilia infection – a case report and review article.Ann. Acad. Med. Singapore35 , 897–900 (2006).
  • Falagas ME , KastorisAC, VouloumanouEK, DimopoulosG: Community-acquired Stenotrophomonas maltophilia infections: a systematic review.Eur. J. Clin. Microbiol. Infect. Dis.28 , 719–730 (2009).
  • Alonso A , MartinezJL: Multiple antibiotic resistance in Stenotrophomonas maltophilia.Antimicrob. Agents Chemother.41 , 1140–1142 (1997).
  • Gattuso G , TomasoniD, CerutiR, ScalziniA: Multiresistant Stenotrophomonas maltophilia tunneled CVC-related sepsis, treated with systemic and lock therapy.J. Chemother.16 , 494–496 (2004).
  • Looney WJ : Role of Stenotrophomonas maltophilia in hospital-acquired infection.Br. J. Biomed. Sci.62 , 145–154; quiz 1 p following 154 (2005).
  • Tan CK , LiawSJ, YuCJ, TengLJ, HsuehPR: Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes.Diagn. Microbiol. Infect. Dis.60 , 205–210 (2008).
  • Zhang L , LiXZ, PooleK: Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.Antimicrob. Agents Chemother.44 , 287–293 (2000).
  • Falagas ME , ValkimadiPE, HuangYT, MatthaiouDK, HsuehPR: Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.J. Antimicrob. Chemother.62 , 889–894 (2008).
  • Nicodemo AC , PaezJI: Antimicrobial therapy for Stenotrophomonas maltophilia infections.Eur. J. Clin. Microbiol. Infect. Dis.26 , 229–237 (2007).
  • Muder RR : Optimizing therapy for Stenotrophomonas maltophilia.Semin. Respir. Crit. Care Med.28 , 672–677 (2007).
  • Turkoglu MA , IskitAT: Ventilator-associated pneumonia caused by high risk microorganisms: a matched case–control study.Tuberk. Toraks56 , 139–149 (2008).
  • Metan G , HayranM, HascelikG, UzunO: Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital.Scand. J. Infect. Dis.38 , 527–531 (2006).
  • Nseir S , Di Pompeo C, Brisson H et al.: Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Crit. Care10 , R143 (2006).
  • Senol E , DesJardinJ, StarkPC, BarefootL, SnydmanDR: Attributable mortality of Stenotrophomonas maltophilia bacteremia.Clin. Infect. Dis.34 , 1653–1656 (2002).
  • Elting LS , KhardoriN, BodeyGP, FainsteinV: Nosocomial infection caused by Xanthomonas maltophilia: a case–control study of predisposing factors.Infect. Control Hosp. Epidemiol.11 , 134–138 (1990).
  • Fisher MC , LongSS, RobertsEM, DunnJM, BalsaraRK: Pseudomonas maltophilia bacteremia in children undergoing open heart surgery.JAMA246 , 1571–1574 (1981).
  • Guriz H , CiftciE, AyberkinE et al.: Stenotrophomonas maltophilia bacteraemia in Turkish children.Ann. Trop. Paediatr.28 , 129–136 (2008).
  • Ansari SR , HannaH, HachemR, JiangY, RolstonK, RaadI: Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.Cancer109 , 2615–2622 (2007).
  • Kagen J , ZaoutisTE, McGowanKL, LuanX, ShahSS: Bloodstream infection caused by Stenotrophomonas maltophilia in children.Pediatr. Infect. Dis. J.26 , 508–512 (2007).
  • Apisarnthanarak A , MayfieldJL, GarisonT et al.: Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case–control study.Infect. Control Hosp. Epidemiol.24 , 269–274 (2003).
  • Labarca JA , LeberAL, KernVL et al.: Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis.Clin. Infect. Dis.30 , 195–197 (2000).
  • Micozzi A , VendittiM, MonacoM et al.: Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.Clin. Infect. Dis.31 , 705–711 (2000).
  • Victor MA , ArpiM, BruunB, JonssonV, HansenMM: Xanthomonas maltophilia bacteremia in immunocompromised hematological patients.Scand. J. Infect. Dis.26 , 163–170 (1994).
  • Maningo E , WatanakunakornC: Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units.J. Infect.31 , 89–92 (1995).
  • Hanes SD , DemirkanK, TolleyE et al.: Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients.Clin. Infect. Dis.35 , 228–235 (2002).
  • Aisenberg G , RolstonKV, DickeyBF, KontoyiannisDP, RaadII, SafdarA: Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997–2004.Eur. J. Clin. Microbiol. Infect. Dis.26 , 13–20 (2007).
  • Villarino ME , StevensLE, SchableB et al.: Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients.Infect. Control Hosp. Epidemiol.13 , 201–206 (1992).
  • Kwa AL , LowJG, LeeE, KurupA, CheeHL, TamVH: The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia.Diagn. Microbiol. Infect. Dis.58 , 99–104 (2007).
  • McGowan JE Jr: Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum. Am. J. Med.119 , S29–S36; discussion S62–S70 (2006).
  • Penzak SR , AbateBJ: Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.Pharmacotherapy17 , 293–301 (1997).
  • Rousseau A , MorcosM, AmroucheL et al.: Lethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient.Leuk. Lymphoma45 , 1293–1296 (2004).
  • Pathmanathan A , WatererGW: Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection.Eur. Respir. J.25 , 911–914 (2005).
  • Dupont H , MentecH, SolletJP, BleichnerG: Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia.Intensive Care Med.27 , 355–362 (2001).
  • Mueller EW , HanesSD, CroceMA, WoodGC, BoucherBA, FabianTC: Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients.J. Trauma58 , 94–101 (2005).
  • Paez J , CostaS: Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia.J. Hosp. Infect.70 , 101–108 (2008).
  • Friedman ND , KormanTM, FairleyCK, FranklinJC, SpelmanDW: Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.J. Infect.45 , 47–53 (2002).
  • del Toro MD , Rodriguez-BanoJ, Martinez-MartinezL et al.: Epidemiology, clinical features and prognosis of infections due to Stenotrophomonas maltophilia.Enferm. Infecc. Microbiol. Clin.24 , 4–9 (2006).
  • Gopalakrishnan R , HawleyHB, CzachorJS, MarkertRJ, BernsteinJM: Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: a study of 143 patients.Heart Lung28 , 134–141 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.